Linton Webinar earlier today...I had an opportunity to listen to Linton's webinar today with Alan Brochstein...
For those who dont want to listen to the hour long interview, I would suggest you jump to the 42 minute mark where he discusses pharmacies followed by the TMX / Aphria issue.
He does not see pharmacies becoming part of the medical distribution channel until after 2018. He believes that Shoppers made a lot of noise when they first applied and then quietly disappeared. So according to Linton, don't expect pharmacies to become part of the medical distribution channel anytime soon.
He then discussed the Aphria / TMX issue right after the Shoppers question. He seems to be conceeding that the issue will be resolved in Aphria's favour and it will be business as "unusual" because he still maintains that Aphria is breaking the law and "enhanced disclosure" should not remedy the situation. He still can't get his head wrapped around the CSA and OSC's decsion to allow "enhanced disclosure" as part of the test for doing business in the US.
What I did find surprising is thet he toned down his criticism of Aphria doing business in the US, conceeding that the "Cole" memo will most likely be included in legislation passed by Congress in December and that nothing will be done and it will be business as "unusal". I can't help but think partnering with CB might have softened his position on doing business in the US, even if it was only a small shift. It will be interesting going forward to watch how he now handles the issue of doing business in the US now that he has a US business partner.
M